News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
628,184 Results
Type
Article (50997)
Company Profile (213)
Press Release (576959)
Multimedia
Podcasts (165)
Webinars (25)
Section
Business (160486)
Career Advice (3115)
Deals (29226)
Drug Delivery (150)
Drug Development (79184)
Employer Resources (186)
FDA (14822)
Job Trends (12792)
News (288569)
Policy (27920)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2556)
Academic (1)
Accelerated approval (55)
ADA (40)
Adcomms (37)
Allergies (179)
Alliances (42936)
ALS (218)
Alzheimer's disease (1749)
Antibody-drug conjugate (ADC) (577)
Approvals (15253)
Artificial intelligence (736)
ASCO (341)
Autoimmune disease (344)
Automation (58)
Bankruptcy (257)
Best Places to Work (10372)
BIO (72)
BIOSECURE Act (19)
Biosimilars (230)
Biotechnology (152)
Bladder cancer (214)
Brain cancer (84)
Breast cancer (858)
Cancer (6715)
Cardiovascular disease (455)
Career advice (2659)
Career pathing (52)
CAR-T (376)
CDC (45)
Celiac Disease (2)
Cell therapy (982)
Cervical cancer (58)
Clinical research (69097)
Collaboration (2190)
Commercialization (1)
Company closure (7)
Compensation (1280)
Complete response letters (99)
COVID-19 (2719)
CRISPR (112)
C-suite (1069)
Cystic fibrosis (155)
Data (8487)
Decentralized trials (2)
Denatured (40)
Depression (189)
Dermatology (90)
Diabetes (589)
Diagnostics (6518)
Digital health (59)
Diversity (12)
Diversity, equity & inclusion (42)
Drug discovery (365)
Drug pricing (188)
Drug shortages (25)
Duchenne muscular dystrophy (282)
Earnings (70048)
Editorial (77)
Employer branding (25)
Employer resources (163)
Events (101675)
Executive appointments (968)
FDA (18640)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (20)
Frontotemporal dementia (35)
Funding (1728)
Gene editing (238)
Generative AI (64)
Gene therapy (739)
GLP-1 (1077)
Government (4772)
Grass and pollen (8)
Guidances (399)
Healthcare (17172)
Hematology (190)
HIV (86)
Huntington's disease (60)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (106)
Immunology and inflammation (297)
Immuno-oncology (118)
Indications (216)
Infectious disease (3079)
Inflammatory bowel disease (223)
Inflation Reduction Act (13)
Influenza (142)
Intellectual property (298)
Interviews (628)
IPO (14746)
IRA (44)
Job creations (2700)
Job search strategy (2123)
JPM (68)
Kidney cancer (23)
Labor market (112)
Layoffs (503)
Leadership (54)
Legal (5289)
Liver cancer (111)
Longevity (31)
Lung cancer (890)
Lymphoma (480)
Machine learning (64)
Management (65)
Manufacturing (1036)
Marketing (4)
MASH (216)
Medical affairs (1)
Medical device (10771)
Medtech (10898)
Mergers & acquisitions (15705)
Metabolic disorders (1583)
mRNA (258)
Multiple sclerosis (200)
NASH (24)
Neurodegenerative disease (455)
Neuropsychiatric disorders (114)
Neuroscience (3347)
Neurotech (1)
NextGen: Class of 2026 (5759)
Non-profit (4150)
Now hiring (72)
Obesity (722)
Opinion (353)
Ovarian cancer (251)
Pain (243)
Pancreatic cancer (374)
Parkinson's disease (375)
Partnered (33)
Patents (598)
Patient recruitment (762)
Peanut (56)
People (46089)
Pharmaceutical (52)
Pharmacy benefit managers (29)
Phase 1 (21895)
Phase 2 (30534)
Phase 3 (22621)
Pipeline (9531)
Policy (326)
Postmarket research (2287)
Preclinical (9385)
Press Release (52)
Prostate cancer (355)
Psychedelics (58)
Radiopharmaceuticals (368)
Rare diseases (1187)
Real estate (4250)
Recruiting (79)
Regulatory (23490)
Reports (56)
Research institute (2430)
Resumes & cover letters (502)
Rett syndrome (47)
RNA editing (26)
RSV (86)
Schizophrenia (189)
Series A (289)
Series B (210)
Service/supplier (9)
Sickle cell disease (123)
Special edition (32)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3146)
State (2)
Stomach cancer (21)
Supply chain (115)
Tariffs (80)
The Weekly (122)
Vaccines (1163)
Venture capital (126)
Weight loss (473)
Women's health (122)
Worklife (25)
Date
Today (58)
Last 7 days (393)
Last 30 days (1932)
Last 365 days (28578)
2026 (15357)
2025 (28582)
2024 (33200)
2023 (37845)
2022 (48387)
2021 (52200)
2020 (50066)
2019 (41748)
2018 (31642)
2017 (29664)
2016 (28360)
2015 (33078)
2014 (25140)
2013 (20527)
2012 (21173)
2011 (21721)
2010 (19875)
Location
Africa (838)
Alabama (84)
Alaska (6)
Arizona (238)
Arkansas (11)
Asia (42059)
Australia (7080)
California (13013)
Canada (3917)
China (1532)
Colorado (540)
Connecticut (573)
Delaware (429)
Europe (87132)
Florida (1924)
Georgia (399)
Hawaii (3)
Idaho (45)
Illinois (1016)
India (86)
Indiana (580)
Iowa (23)
Japan (587)
Kansas (124)
Kentucky (43)
Louisiana (48)
Maine (84)
Maryland (1556)
Massachusetts (9446)
Michigan (330)
Minnesota (592)
Mississippi (4)
Missouri (141)
Montana (34)
Nebraska (21)
Nevada (136)
New Hampshire (72)
New Jersey (3536)
New Mexico (27)
New York (3501)
North Carolina (1569)
North Dakota (8)
Northern California (6632)
Ohio (365)
Oklahoma (17)
Oregon (39)
Pennsylvania (2441)
Puerto Rico (23)
Rhode Island (34)
South America (1062)
South Carolina (70)
Southern California (5157)
Tennessee (165)
Texas (2095)
United States (45602)
Utah (367)
Vermont (2)
Virginia (326)
Washington D.C. (65)
Washington State (1067)
West Virginia (3)
Wisconsin (127)
628,184 Results for "can fite biopharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Can-Fite Secures Japanese Patent Allowance for Namodenoson’s Anti-Obesity Technology
June 26, 2026
·
7 min read
Can-Fite Publishes Peer-Reviewed Scientific Article Demonstrating the Broad Therapeutic Potential of Piclidenoson and Namodenoson
June 22, 2026
·
5 min read
Press Releases
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
June 17, 2026
·
6 min read
Press Releases
Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease
July 1, 2026
·
7 min read
Press Releases
Can-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone with Completion of Patient Enrolment for the Interim Analysis: Data Expected Q4 2026/Q1 2027
July 6, 2026
·
6 min read
Press Releases
Scientific Publication of Can-Fite and Vetbiolix Validates Piclidenoson’s Potential in the Multi-Billion Dollar Canine Osteoarthritis Market
May 18, 2026
·
7 min read
Press Releases
Can-Fite Reports Positive Clinical Observation in Phase 2a Pancreatic Cancer Study and Highlights Namodenoson’s RAS Signaling Inhibition Mechanism
June 2, 2026
·
6 min read
Press Releases
Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy
May 13, 2026
·
6 min read
Press Releases
Can-Fite Expands Namodenoson anti-Obesity Franchise with Israeli Patent Allowance
March 17, 2026
·
6 min read
Sponsored
What Biopharma Can Learn from Formula 1: Precision, Speed, and the Power of the Right Partner
As the Formula 1 season kicks off in the APAC region, biopharma companies can take a page from the popular sport’s playbook around precision, adaptability, and the right team. In return, biopharma can also offer some lessons to elite motor sport on well-rounded excellence in the race to market.
March 16, 2026
·
5 min read
1 of 62,819
Next
